June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Inflammasome facilitates ganglion cell dysfunction and loss in ocular hypertension glaucoma
Author Affiliations & Notes
  • Valery Shestopalov
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
    Cell Biology, University of Miami School of Medicine, Miami, Florida, United States
  • Markus Spurlock
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
    Neurology, University of Miami School of Medicine, Miami, Florida, United States
  • Weijun An
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Galina Reshetnikova
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Tsung-Han Chou
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Gabriela S Solis
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Aleksey Pronin
    Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida, United States
  • Michelle Braha
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Galina Dvoriantchikova
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Vittorio Porciatti
    Bascom Palmer Eye Institute, Dept. Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Valery Shestopalov None; Markus Spurlock None; Weijun An None; Galina Reshetnikova None; Tsung-Han Chou None; Gabriela Solis None; Aleksey Pronin None; Michelle Braha None; Galina Dvoriantchikova None; Vittorio Porciatti None
  • Footnotes
    Support  NIH Grants EY021517, R21EY032261, RO1EY018666, F31 EY032789-01A1 and Core P30 EY014801 to the Department of Ophthalmology, an unrestricted RPB and DOD grant DAMB W81XWH-13-1-0048 to the Department of Ophthalmology
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 918 – A0387. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Valery Shestopalov, Markus Spurlock, Weijun An, Galina Reshetnikova, Tsung-Han Chou, Gabriela S Solis, Aleksey Pronin, Michelle Braha, Galina Dvoriantchikova, Vittorio Porciatti; Inflammasome facilitates ganglion cell dysfunction and loss in ocular hypertension glaucoma. Invest. Ophthalmol. Vis. Sci. 2022;63(7):918 – A0387.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine molecular pathways facilitating retinal ganglion cell (RGC) dysfunction and death in response to ocular hypertension (OHT)-induced stress. In this study, we sought to establish the contribution of the inflammasome to RGC pathology in a mouse model of OHT-induced glaucoma.

Methods : Glaucomatous degeneration was induced by intracameral injection of the Ad5-MYOC vector that produced a chronic IOP elevation. Inflammasome activation was detected by IL-1β production, changes in casp1, pycard (ASC), nlrp1, and gsdmD gene expression, and protein accumulation using RT-PCR, Western blot, and immunohistochemistry. Wild type and knockout mouse strains were used to determine the role of the inflammasome in ocular hypertension glaucoma. IL-1β cytokine production was assessed by sandwich ELISA in the vitreous fluid; gene expression changes in the retina, by RT-PCR. Changes in RGC functionality were assessed by PERG recordings; RGC loss was assessed at 8 wks post-OHT induction by direct counts in retinal flat mounts.

Results : Activation of the inflammasome became evident in the inner retinal layer and co-localized with RPBMS+ RGCs in C57Bl6 (WT) mice at 2-4 wks after glaucoma induction. This correlated in time with RGC dysfunction, where PERG amplitude was reduced 55.8% in WT eyes with chronic OHT glaucoma. RGC density analysis in these animals showed a loss of 32.3±9.2 % in the central and 28.4±9.2 % in the peripheral retina at 6 wks post-OHT-induction. In contrast, mice are deficient in key inflammasome complex proteins NLRP1, Casp1 and GsdmD did not produce statistically significant changes in PERG amplitude. RGC loss was also blocked, averaging 0.7±11.2% increase in the central and no change in the peripheral retina of NLRP1-/- eyes; 7.3± 9.2% decrease in the central and 1.3 ±19.5 % increase in the peripheral retina of Casp1-/- eyes. Immunohistochemistry data in retinal cross-sections showed the absence of Casp1 and a reduction in GsdmD immunolabeling labeling in RGCs in the knockout retinas with induced glaucoma.

Conclusions : Our results show a strong correlation between the elevation of IOP, induction of inflammasome, and RGC pathology in the retina. Our results in mice deficient for inflammasome pathway components revealed the key role of the inflammasome in driving RGC dysfunction and cell death. Drugs inhibitors of inflammasome could protect vision loss in human ocular hypertension glaucoma

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×